Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma

Category

Published in:

Frontiers in Pharmacology  
Vol. 14 (03.04.2023)

Volume:

14

Date Issued:

03.04.2023

DOI:

10.3389/fphar.2023.1188062

Language:

English

Type of Resource:

Text

Keywords:

hepatocellular carcinoma; drug resistance; sorafenib; lenvatinib; regorafenib; cabozantinib

DDC subject of DNB:

610 Medical sciences Medicine